Skip to main content

FDA Updates

Recent Cancer Drugs Approved by the FDA

Actemra First FDA-Approved Treatment for CAR T-Cell–Induced Severe Cytokine Release Syndrome

Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML

Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer

Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL

Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19

FDA News - September 2017

FDA News - August 2017

FDA News - June 2017

Welcome to the Second Annual Oncology Pharmacy Guide to New FDA Approvals

22
23
24
25
26
27
28

Page 25 of 33
Results 241 - 250 of 330